drugset / Trial / NCT01285570
Ulimorelin Study of Efficacy and Safety (ULISES 007)
RandomizedParallel-groupTriple-blindTreatment
Summary
Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ulimorelin | Small molecule | 160 ug/kg | Intravenous |
| Subject | Ulimorelin | Small molecule | 480 ug/kg | Intravenous |